Table 1 Patient characteristics

From: Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

Characteristics

No. (%)

Total no. of patients

54

Sex

 Male

49 (91)

 Female

5 (9)

Age (years)

 Median

59

 Range

40–75

Performance status (ECOG)

 0

35 (65)

 1

18 (33)

 Unknown

1 (2)

Weight loss (%)a

 Median

2

 Range

0–12

Histology

 Adenocarcinoma

41 (76)

 Squamous cell carcinoma

12 (22)

 Large cell carcinoma

1 (2)

Barrett's oesophagus b

 Yes

19 (46)

 No

17 (42)

 Uncertain

5 (12)

Stage (EUS)

 T2N0

5 (9)

 T2N1

2 (4)

 T3N0

18 (33)

 T3N1

21 (39)

 No pass

8 (15)

Primary site

 Thoracic oesophagus

5 (9)

 Lower oesophagus

49 (91)

  1. aCalculated from the data of 52 patients.
  2. bCalculated in 41 patients with adenocarcinoma. Yes=Barrett's oesophagus identified by upper endoscopy and confirmed by histopathologic examination. No=No Barrett's oesophagus identified by upper endoscopy or by histopathologic examination. Uncertain=Barrett's oesophagus identified by upper endoscopy or by histopathologic examination.
  3. EUS, Endoscopic ultrasound.
Back to article page